Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma

NCT01737905 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Epinephrine HFA-MDI (E004)
DRUG: Placebo-HFA

Sponsor

Amphastar Pharmaceuticals, Inc.